Cargando…
SAT-485 Variations in the Time Course of Pembrolizumab-Induced Thyroiditis: A Case Series
Variations in the Time Course of Pembrolizumab-Induced Thyroiditis: A Case Series Introduction: Thyroid dysfunction is reported in 5 - 9.5 % of patients treated with Pembrolizumab, one of the PD-1 immune checkpoint inhibitors. However, the underlying mechanism of Pembrolizumab-induced thyroid disord...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207765/ http://dx.doi.org/10.1210/jendso/bvaa046.155 |